Which hedge funds own LYEL? LYELL IMMUNOPHARMA INC, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in LYEL (LYELL IMMUNOPHARMA INC) in their Q2 2026 13F filings, worth $9.3m in total. The largest holder by portfolio weight is Millennium Management at 0.0% of its book.
6tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold LYEL? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Millennium Management | Q2 2026 | 0.0% | $5.2m | 367,473 | -20% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.8m | 130,190 | 12% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $162.4k | 11,557 | -14% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.5m | 106,300 | -28% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $366.4k | 26,080 | 22% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $262.7k | 18,695 | -95% | reduced |
How has hedge fund ownership of LYEL changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $9.3m |
| Q1 2026 | 6 | $22.9m |
| Q4 2025 | 2 | $1.6m |
| Q3 2025 | 1 | $1.0m |
| Q2 2025 | 2 | $1.5m |
| Q1 2025 | 2 | $1.0m |
| Q4 2024 | 2 | $1.1m |
| Q3 2024 | 3 | $651.5k |
| Q2 2024 | 4 | $683.2k |
| Q1 2024 | 6 | $3.4m |
| Q4 2023 | 4 | $2.0m |
| Q3 2023 | 3 | $1.6m |
| Q2 2023 | 3 | $1.5m |
| Q1 2023 | 2 | $2.4m |
| Q4 2022 | 3 | $3.9m |
| Q3 2022 | 3 | $3.3m |
Counts every tracked manager that disclosed LYEL in that quarter's filing, including managers that have since stopped filing.